Pennington Biomedical’s Dr. Gang Hu appointed to NIH Reproductive, Perinatal and Pediatric Health Review Group
Business Announcement
Updates every hour. Last Updated: 18-Jun-2026 10:16 ET (18-Jun-2026 14:16 GMT/UTC)
Smoking tobacco is known to worsen symptoms of periodontitis and reduce responsiveness to treatment. Using high-resolution spatial transcriptomics, researchers identified differences between smokers and non-smokers in the expression of genes that weaken gum epithelial integrity and cause bone damage through inflammation. They also identified CXCL12 secreted by endothelial cells in gums as a crucial mediator of immune-cell recruitment that drives excessive inflammation. CXCL12 is a possible target for new therapies against periodontitis aggravated by smoking.
Cilk1 deficiency disrupts normal tooth development by altering primary cilia function and weakening Hedgehog signaling. This reduction triggers extra diastemal teeth, enlarges them under further signaling loss, and can ultimately cause molar fusion. Researchers propose a progressive model linking Hedgehog signaling levels to sequential changes in tooth patterning. The study highlights a previously unknown role for Cilk1 in shaping tooth morphology and improving understanding of developmental dental disorders in humans.
A team led by Prof. Richard GU Hongri, Assistant Professor in the Division of Integrative Systems and Design of the Academy of Interdisciplinary Studies at The Hong Kong University of Science and Technology (HKUST), in collaboration with experts in mechanical engineering and biomedicine, has developed an automated robotic nanoprobe. This device can navigate within living cell, sense metabolic whispers in real time, and pluck an individual mitochondrion for analysis or—all without the need for fluorescent labeling. It is the world’s first cell-manipulation nanoprobe that integrates both sensors and actuators at its tip, enabling a micro-robot to autonomously navigate inside live cells. The breakthrough holds great promise for advancing future treatment strategies for chronic diseases and cancer.
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS). The study, published in Nature Neuroscience, reveals an early weakness in neurodegeneration and highlights a potential target for future therapies.